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T cell-mediated responses to mycobacterial antigens (Ags)' have been implicated
in the pathogenesis of inflammatory arthritis both in experimental animals and in
man (1-3) . In adjuvant arthritis (AA) in rats, it has been clearly established that
thedisease can be initiated byT cell lines and clones specific for the65-kD mycobac-
terial heat-shock protein (HSP) (4) ; the epitope recognized by the arthritogenic T
cell clone has been localized to amino acids 180-188 . Animals can also be rendered
resistant to the induction ofAA by prior immunization either with 65 kD-specific
T cell clones or with the 65-kD Ag itself (4, 5) . Interestingly, previous challenge
with mycobacteria165-kD Ag is also effective in preventing the arthritis induced by
streptococcal cell walls or by pristane (6, 7) .A role forthe 65-kD Ag is not confined
therefore to arthritis induced by mycobacterial Ags.
That these observations in animal models of arthritis may be relevant to arthritis
in manhas been suggested by the finding thatT cells from synovial fluid frequently
respond to the65-kD Ag (8-10) . These responses are more marked in synovial fluid
than in peripheral blood . Recently T cell clones that use either a/# or y/b receptors
in their recognition ofthe 65-kDAg have also been isolated from thejoint (11), while
elevated titres of antibody to the 65kD Ag have also been reported in rheumatoid
arthritis (12, 13).
The mechanisms whereby immune responses to the 65-kD Ag result in arthritis
are not known . Ahomology noted between the 65-kD antigenic epitope implicated
in AA and the link protein of cartilage proteoglycan raised the possibility that 65
kD-specificTcellsmight crossreact with this autoantigen (4) . However, further studies
have shown that the homologous peptide from link protein does not stimulate the
arthritogenic T cell clone (14) . Attention has also been focused on the fact that the
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65-kD Ag is highly conserved, not only among bacteria (15), but also in eukaryotes
(16), so that some Tcells might respond to epitopes common to both the bacterial
and eukaryotic Ag. Since HSPs may be produced at sites of inflammation (17), T
cellsinitially inducedby bacterialAgs could conceivably mediate autoimmune disease.
In this paper we describe human 65 kD-specific T cell clones, isolated from the
synovial fluid ofapatient with an acute, self-limiting inflammatory arthritis. Using
synthetic peptides, these were shown to respond to an epitope that is mycobacteria
specific.
Materials and Methods
Patient.
￿
Synovial fluid (SF) was aspirated from the knee of a 53-yr-old white man who
had developed acute lower limb inflammatory arthritis 2 wk previously. The arthritis was
preceded by a florid conjunctivitis and low back pain. In view ofthese clinical features a diag-
nosis ofreactive arthritis (18) was made, but there was no history of preceding gastrointestinal
or genito-urinary infection and no serological evidence ofpreceding infection by Salmonella,
Campylobacter, Yersinia, or Chlamydia. The arthritis resolved rapidly over the following month
and has not recurred. The patient's HLA type was Al, B8, DR3.
Proliferation Assays.
￿
SF mononuclear cells (SFM) and PBMC were isolated and tested for
their proliferative responses to mitogens and bacterial Ags as previously described in detail
(9, 19). Briefly, 5 x 10' SFM or PBMC were suspended in RPMI 1640 medium containing
2 mM glutamine, 100,ug/ml streptomycin, 100 U/ml penicillin (complete medium [CM]),
supplemented with 10% FCS and 1% human serum (HS), and cultured for 6 d in triplicate
0.2 ml U-bottomed 96-well microtiter plates (Nunc, Roskilde, Denmark) at 5 x 10' cells/well.
[3H]Thymidine incorporation (disintegrations per minute [dpm]) was measured during the
last 18 h of culture. The stimulation index (SI) was defined as {3H]thymidine incorporation
in the presence of Ag divided by [3 H]thymidine incorporation in the presence of medium
alone.
Antigens.
￿
Purified protein derivative of tuberculin (PPD) was obtained from Statens
Seruminstitut, Copenhagen, Denmark. Fscherichia coli GroEL (20) was a kind gift ofDr. Douglas
Young, Hammersmith Hospital, London, UK. The recombinant 65-kD Ag ofMycobacterium
leprae was prepared as described in reference 21. Suspensions of bacteria associated with reac-
tive arthritis were sterilized by heat or irradiation before use in proliferation assays and soluble
Salmonella Ags prepared using 0.1% SDS (SA/SDS) as previously described (10).
Synthetic Peptides.
￿
A library consisting of 106 overlapping peptides, of between 15 and 19
amino acids in length, was synthesized using a simultaneous multiple-peptide solid-phase
synthetic method (22) using a polyamide resin (23) and FMOC chemistry. Completed pep-
tides were extracted from the resin using trifluroacetic acid and suitable scavengers, and iso-
lated by solvent evaporation and precipitation with methanol and diethylether. Purity was
checked by aminoacid analysis, and by HPLC.
T Cell Cloning.
￿
T cell blasts were harvested from 6-d cultures of SFM stimulated with
the 65-kD Ag and cloned by limiting dilution in 0.2 ml wells using 4 x 10' irradiated (3,000
rad) autologous (auto)PBMC as APC, 100 U/ml rIL-2 (24) (Cetus Corp., Emeryville, CA),
and 20 tag/ml 65 kD, in CM supplemented with 5% HS, 1% nonessential amino acids, and
1 % sodium pyruvate. Growing colonies were transferred to fresh wells on day 13 and restimu-
lated with 105 irradiated allogeneic PBMC, 1 Fig/ml purified PHA (Wellcome, Beckenham,
UK), and 100 U/ml IL-2 in CM supplemented as for cloning. Expansion was continued by
twice weekly feeding with IL-2 and restimulation every 10-14 d with allogeneic (allo)PBMC
and PHA. Clones were only tested in proliferation assays at least 7 d after restimulation.
The phenotype of clones was determined by staining with mAbs and flow cytometry.
Determination ofthe Antigenic Specificity ofClones.
￿
Clones were screened for responses to the
65-kD Ag by removing an aliquot of cells, washing in fresh medium, and coculture with 105
irradiated autoPBMC with or without the 65-kD Ag (10 jug/ml) for 72 h. [3H]Thymidine
incorporation was measured as above. In subsequent proliferation assays 10' T cell/well were
used. In addition to PBMC, auto- and allo-EBVtransformed lymphoblastoid cells (EBLCL)GASTON ET AL.
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were used as APC. These were cultured overnight in CM containing 5% HS with or without
Ag, and then irradiated (6,000 rad) before culture with the T cells. Soluble Ag was also in-
cluded in these assays. In assays using synthetic peptides, the peptide was applied to nitrocel-
lulose (nc) discs (Hybond-C; Amersham Corp., Amersham, UK), which were then dried
under vacuum, sterilized by irradiation, and placed directly into culture wells containing
the T cell clone and APC (cf. reference 25). SIs were calculated as described above.
The effect of mAbs specific for HLA Ags on T cell proliferation was tested by culturing
the appropriate mAb dilution with APC for 30 min before the addition ofT cells. mAb W6/32
(HLA-A,B,C-specific) and RFBI (HLA-DRspecific) were obtained from Seralab (Crawley,
Sussex, UK) and used as ascites; L243 (American Type Culture Collection, Rockville, MD),
an HLA-DRspecific mAb, was used as hybridoma supernatant.
The cytotoxicity of clones was assessed by measuring "Cr release from autologous Ag-
pulsed macrophages after 16 h of coculture with T cells at an E/T ratio of 5:1, as described
in detail elsewhere (26).
Results
Proliferative Responsesto M . leprae 65-kDAntigenby SFMandPBMC .
￿
SFM and PBMC,
isolated from a patient with acute inflammatory arthritis, were tested for their ability
to respond to bacterial Ags (Fig. 1). Although the clinical picture was suggestive of
reactive arthritis, unlike the majority o£ such patients (see reference 19) the SFM
did not respond to any of the organisms tested that are known to trigger arthritis.
However, a marked response to the recombinant 65-kD Ag of M. leprae was noted;
this was similar in magnitude to the response to an optimal concentration of PPD
(representing multiple mycobacterial Ags, including the 65-kD Ag). The prolifera-
tive responses of PBMC tested concurrently were generally low, but a significant
response to PPD was recorded (SI similar to that seen using SFM; Fig. 1 b), whereas
no PBMC response to the 65-kD Ag could be detected . These SFM and PBMC
were tested on two occasions with the same results. To investigate in detail the marked
recognition of the 65-kD Ag by the SFM, cloning studies were undertaken.
Properties ofSynovial Fluid-derived65-kD-specific TCell Clones.
￿
22/31 T cell clones,
derived from wells seeded with 0.3-10 T cell blasts (obtained from SFM stimulated
for 6 d with 65-kD Ag), were found to respond specifically to the 65-kD Ag. Two
clones (from cultures seeded at 1 cell/well) were characterized in detail; by flow cytom-
etry analysis they,were both CD3 + , CD4+, CD8- , TCR61 - . Single rearrangements
ofboth TCR R and ti chain genes, consistent with clonality, were noted when DNA
from the clones was compared with that of the autologous EBLCL by Southern blot-
ting, using both a and -y chain gene-specific probes (data not shown). Evidence for
their antigenic specificity is given in Table 1. Both clones proliferated in response
to the recombinant M. leprae 65-kD Ag, and to PPD, presented by either autologous
or HLA-DR3-matched PBL and EBLCL. The apparent restriction by HLA-DR
was confirmed by blocking studies; an HLA-DR-specific mAb (RFBI) decreased
proliferation to a much greater extent than the anti-class I mAb, W6/32 (Table II).
The response to Ag was essentially abolished by RFBI whereas that to PHA and
IL-2 was still evident even at the highest mAb concentration used. Another HLA-
DR-specific mAb (L243) also inhibited the response to Ag by >80% (data not shown).
In addition to proliferative responses, both clones were capable of lysing PPD- or
65-kD-pulsed macrophages (29 and 27 % lysis of PPD-pulsed macrophages; 51 and
43% lysis of 65-kD-pulsed macrophages by clones MAW1.4 and MAW1.5, respec-
tively).834
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￿
Proliferative responsesofPBMC and SFM, obtained concurrently, to themitogenic
andantigenic stimulishown. (A) [3H]Thymidineincorporation; (B)Stimulation index. 5 x 104
PBMC or SFM were cultured with PHA (1 Ag/ml), IL-2 (20 U/ml), PPD (10 lAg/ml), 65 kD
(10Ag/ml), and bacterial suspensions (Yersinia entemcolitica 0:3 (Yers), 106organisms/ml; Salmonella
agona(Salm), Chlamydia trachomatis elementary bodies (Chlam)and Campylobacterjejuni (Campyl),
108 organisms/ml. [3H]Thymidine incorporation was measured after 6 d.
Mapping of the Epitopes within the 65-kD Ag Recognized by Synooial T Cell Clones.
￿
A
panel of 106 overlapping peptides of between 15 and 19 amino acids in length and
corresponding to the complete sequence of the 65-kD Ag (27) was used for epitope
mapping. The peptides were divided into 11 pools for initial screening. Table III,
Exp. a, shows that usingclone MAW1.4 only pool 1 (peptides 1-10) proved stimula-
tory; in addition, neither recombinant E. coli 65 kD (GroEL) nor soluble Ags de-
rived from Salmonella were recognized, indicating that the epitope seen was un-
likely to be found in a conserved region of the 65-kD sequence. When the peptides
comprising pool 1 were tested individually (Table III, Exp. b), only peptide 1 (amino
acids 1-15)was stimulatory; the partially overlapping peptide 2 (amino acids 6-22)
gave only background proliferation. The sequence of peptide 1 is shown in TableGASTON ET AL.
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TABLE I
Specificity of Clones MA W1.4 and MA W1.5
104 T cells were cocultured with 105 irradiated autoPBMC (1,500 rad) or 104 auto- or allo-
EBLCL (6,000 rad) in CM supplemented with 5-10% HS . Ag concentrations were 20 Rg/ml
and 7.5 ug/ml for 65 kD in Exp. 1 and 2 respectively, and 10 lAg/ml for PPD. Before irradia-
tion, EBLCL were cultured overnight either in CM-5% HS alone, or with 10 Ftg/ml 65 kD
or 20 Wg/ml PPD. [3H]Thymidine incorporation by triplicate (Exp. 2 and 3) or duplicate (Exp.
1) cultures was measured after 3 d. The results are shown as dpm after subtraction of the
[ H]thymidine incorporation by the corresponding APC when cultured alone; the latter is
shown in parentheses.
IV. Twootherclones (including MAW1.5)tested in parallel with MAW1 .4 gave iden-
tical results.
To determinewhetherthese threeclones were typicalof allthose obtained, further
65-kD-responsive clones were tested for their ability to respond to peptides. The
results for 11 clones are summarized in Table V . Again pool 1 stimulated responses
by the majority ofclones tested, but the clearest resultswere obtained usingpeptide
1 alone. All 11 of these clones, and indeed all 15 of the 65 kD Ag-specific clones
tested responded to this peptide. Control autologous clones that did not respond
to the 65-kDAg also failed to recognize peptide 1 (data not shown). The differences
in the results obtained when using pool 1 and peptide 1 may well reflect inhibition
by peptides that can bind to DR3 but that do not contain theT cell epitope. Peptide
9 wasweakly stimulatory foroneclone(SI = 14.4); however, since thecorresponding
SI forpeptide 1 was 163, the significance ofthis weak response to peptide9 is uncertain.
Dominanceof the Response to Peptide X in a Polyclonal TCell Population.
￿
PBMC, ob-
tained 3 mo after resolution of the arthritis, were tested for their proliferative re-
sponses. These PBMC, in marked contrast to thosetested earlier, showed asignificant
response to the 65-kD Ag (Fig. 2). Furthermore, peptide 1 elicited aresponse similar
to that seen usingthewhole 65-kD Ag molecule, suggesting that the epitopeidentified
by using SFM-derived clones was also dominant in the response mounted by the
peripheral T cell population.
Exp. Stimulus
Proliferative response ([3H]thymidine
incorporation)
Clone MAW1 .4 Clone MAW1 .5 APC alone
dpm
1 Medium 264 186
Auto PBMC 150 58 256
Auto PBMC + 65kD 18,998 16,546 596
2 Medium 136 122
Auto EBLCL 420 674 2,979
Auto EBLCL + 65kD 19,781 16,658 2,769
3 Medium 178 262
MR EBLCL (DR3 +) 71 117 602
MR EBLCL (DR3+) + PPD 18,996 10,890 665
SW.EBLCL (DR3-) -83 45 1,009
SW.EBLCL (DR3 -) + PPD 234 -16 757
NT.EBLCL 147 238 103
NT.EBLCL + PPD 250 321 409836
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TABLE II
Inhibition of the 65 kD-speck Proliferative Response of
Clone AM W1.4 by nL4bs
104 MAW1.4 T cells were cocultured with 4 + 104 allogeneic irradiated PBMC
(3,000 rod) from DR3+ donor MR (see Table I), and either 10 Wg/ml 65-kD
Ag or 1 jig/ml PHA + 50 U/ml IL-2. Appropriate dilutions of mAbs RFB1
and W6/32 were added to the PBMC that were incubated at 37°C for 30 min
before the addition of T cells. [3H]thymidine incorporation was measured after
3 d. All cultures were performed in triplicate. T cells cultured with the APC
in the absence of Ag, or with IL-2 in the absence of PHA and APC, gave 291
and 1534 dpm, respectively; APC cultured alone gave 138-dpm.
Discussion
Interest in the role of the 65-kD heat-shock protein in joint inflammation stems
in part from its implication in the pathogenesis ofAA (3, 4) and other forms of ex-
perimental arthritis (6), coupled with evidence that immune responses to this same
Ag may be prominentin human subjects with arthritis, particularly within theinflamed
joint (2, 8-10). In AA, an arthritogenic clone was shown to respond to the epitope
formed by amino acids 180-188. In this report we have mapped the antigenic epi-
tope recognized by a series of SFderived T cell clones from a patient with an acute
inflammatory arthritis. In all casesthe response was to an epitope contained within
aminoacids 1-15 butnot 6-22. Aminimalpeptide has notbeen established for these
clones, but the epitope is likely to be identical to that previously described for clones
from a DR3+ leprosy patient (amino acids 2-12) (28, 29). It is of interest that this
epitope is the only one so far described for DR3-restricted 65-kD antigen-specific
Tcells. In the present case (a DR3 homozygous individual), postarthritis PB T cells
also gave a marked response to the peptide, suggesting that this single epitope
dominates the Tcell response to the 65-kD Ag, and thus to mycobacterial Ags, since
the response to the 65-kD Ag was a substantial proportion of the response to all
the mycobacterial Ags represented within PPD. It is likely that more than one 65
kD-derived peptide is capable of binding to DR3, so that the recognition of asingle
peptide implies that the T cell repertoire for the 65-kD Ag is markedly restricted
in DR3+ individuals. Despite this, DR3 is associated with immunoresponsiveness
to mycobacterial Ags (30), and it is relatively rare for lepromatous leprosy (i.e., T
cell nonresponder) patients to be DR3+ (31). DR3-bearing haplotypes are also
strongly associated with autoimmune diseases (32) (thoughnotarthritis), butwhether
there is any relationship between the dominant response to a single epitope in the
mycobacterial 65-kDAg and susceptibility to autoimmunity remains to be established.
Proliferative response ([3H]thymidine
incorporation) at antibody concentration of:
None 1 :10,000 1:1,000 1:100
(a) RFB1 (anti-class II)
T + APC + 65 kD 26,452 19,462 13,375 1,242
T + APC + IL2/PHA 26,960 21,290 20,993 14,020
(b) W6/32 (anti-class I)
T + APC + 65 kD 21,791 25,669 23,875 ND
T + APC + IL2/PHA 23,510 21,578 15,270 NDT
4
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TABLE III
Proliferative Responses of Synovial Clone MAW]. 4 to Synthetic Peptides
Corresponding to the M. leprae 65-kD Ag
104 T cells were cocultured with 5 x 104 irradiated autoPBMC (3,000 rad).
The Ags 65 kD, GroEL, SA/SDS, and PPD were all used at a final concentra-
tion of 10 jAg/ml. 65 kD and pooled or individual peptides (4 JAI per fraction,
using Ags at 1 mg/ml) were applied to nc as described in Materials and Methods
resulting in a final concentration of 20 ug/ml for 65 kD and individual pep-
tides and 2 ug/ml for each peptide constituent of the pools. [3H]Thymidine
incorporation by triplicate cultures was measured after 3 d. APC cultured alone
gave 162 dpm .
Exp. a, pooled peptides.
Exp. b, individual peptides from pool 1 .
PBS or antigen applied to nitrocellulose as described in Materials and
Methods .
In AA, the 65 kD-specific clone has been shown directly to be able to initiate
disease (1, 5); the involvement of the human 65 kD-specific clones in the pathogen-
esis ofjoint inflammation must remain more conjectural. Nevertheless, the marked
response to the 65-kD Ag in SF, which was not reflected in PB during acute inflam-
mation, is striking. This response wasofasimilarmagnitude to theresponse to PPD;
in contrast, when aresponse to the 65-kDAg appeared in PB it accounted for -50%
of the response to PPD. This suggests that there may have been some localization
of 65 kD-specific T cells within the synovial compartment during Acute inflamma-
tion. Synovial T cells show a surface phenotype associated with memory cells (33),
but whether all memory T cells are recruited equally to a site of inflammation is
not known.
Thedominant epitope seen by the SF T cells proved to be in a nonconserved por-
Stimulus
Exp. a'
Proliferation Stimulus
Exp. bl
Proliferation
PBSncs 171 PBSnc 228
65kDnc 17,555 65kDnc 15,504
Pool 1 4,408 Peptide 1 11,809
Pool 2 190 Peptide 2 322
Pool 3 193 Peptide 3 117
Pool 4 793 Peptide 4 142
Pool 5 137 Peptide 5 294
Pool 6 131 Peptide 6 218
Pool 7 369 Peptide 7 108
Pool 8 190 Peptide 8 167
Pool 9 193 Peptide 9 129
Pool 10 234 Peptide 10 110
Pool 11 170 Pool 1 1,189
Pool 1-11 258 Pool 3 95
Pool 5 102
Pool 11 115
Medium 137 Medium 307
65kD 29,522 65kD 27,948
GroEL 137 GroEL 259
SA/SDS 487 SA/SDS 446
PPD 32,110 PPD 18,849838
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TABLE IV
Sequence of Stimulatory Peptide 1from the M . hprae 65-kD Ag
Aminoacid number
1
￿
15
M A K T I A Y D E E A R R G L
Sequence of the N112-terminal 15 amino acids of the M.leprae 65-kD Ag using
the single letter amino acid code. Residues conserved in both GroEL and the
human 65-kD homologue are underlined.
tion ofthe 65-kDAg(Table IV); this was alsothecase forthe 180-188 epitope recog-
nized by the rat arthritogenic clone. Thus, neither rat AA, nor the present case of
human arthritis, is related to T cells specific for epitopes common to the bacterial
andeukaryotic (self) 65-kDAg, although such clones have been demonstrated (34).
The rat clone also responds to rat proteoglycan (4, 35), but the particular protein
containing the putative crossreactiveepitope has notyet been identified. Thehuman
synovial 65 kD-specific clones will now be tested for crossreactive responses tojoint
constituents including proteoglycan and collagen. In addition, it will be ofinterest
todetermine theTCRVregion genes used to recognize65kD Ag-specificepitopes,
since recent work in experimental encephalomyelitis has shown that recognition of
myelin basis protein by encephalitis-inducing T cell clones is associated with the
use of particular V region genes (36).
TABLE V
Proliferative Responses of MAWSynovial T Cell Clones to
Synthetic Peptides Corresponding to the M. leprae 65-kD Ag
104 T cells were cocultured with 5 x 104 (Exp. 1) or 105 (Exp. 2) DR3 + allo-
PBMC (donor MR, Tables I andII) and Ags or peptides appliedto nc as described
in Table III. [5H]Thymidine incorporation by triplicate cultures was measured
after 3 d. SIs for each Ag:clone combination were calculated by reference to the
PBSnc control.
Exp Ag Mean SI Range
1 (5 clones) 65kDnc 67 .5 29.9-141 .8
SA/SDSnc 1 .0 0.8-1 .6
Peptide 1 12.1 5.0-22.4
Peptide 5 0.7 0.5-0 .9
Peptide 10 0.9 0.6-1 .1
Pool 1 4.0 2.1-8 .6
Pool 5 0.9 0.6-1 .1
Pool 11 1 .1 0.8-1 .8
2 (6 clones) 65kDnc 91 .8 23.7-328.5
SA/SDSnc 1 .5 0.7-1 .6
Peptide 1 45.1 5.1-163 .0
Peptide 4 1 .4 0.8-2 .2
Peptide 9 3.9 1.2-14.4
Pool 1 5.3 1.3-13.9
Pool 5 1.4 1.0-2.2
Pool 11 1 .1 0.8-1 .8FIOuRE 2.
￿
Proliferative responses ofPBMC obtainedafter recovery from arthritis toPPA GroEL,
65 kD (all 10 beg/mP, and pooled or individual 65 kD-related peptides. Results are shown as
SI (solid bars) or [ H]Thymidine incorporation (shaded bars). See Table I for details of the
proliferation assay.
Summary
Adjuvant arthritis in rats is induced by a T cell clone specific for amino acids
180-188 ofthe mycobacterial 65-kDheat-shock protein, and synovial T cell responses
to this sameAghave been noted in human arthritis. We have isolated 65-kD Ag-specific
T cell clones from synovial fluid mononuclear cells of a patient with acute arthritis,
which, unlike the corresponding PBMC, showed a marked proliferative response
to the 65-kD Ag. Using synthetic peptides corresponding to the whole sequence of
the 65-kD Ag, all the clones were shown to recognize an epitope present in the first
N112-terminal peptide (amino acids 1-15), with no response to the adjacent pep-
tide (amino acids 6-22) or to any other peptide. The complete dominance of this
epitope in the response to the 65-kD Ag was shown by documenting responses to
the peptide in PBMC obtained after recovery from the arthritis. This epitope, like
that recognized by the rat arthritogenic T cell clone, is in a portion of the 65-kD
sequence that is not conserved between bacteria and eukaryotes, so that in this case,
joint inflammation could not be attributed to bacteria-induced T cell clones cross-
reacting with the self 65-kD Ag.
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